Research Into Biomarkers Predictive of Survival and Respo... | NCT06851975

Studies
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

NCT06851975

Sponsor

Centre Antoine Lacassagne

Status

Recruiting

Last Update Posted

May 29, 2026Actual

Enrollment

40,000Estimated

Phase

Not provided

Conditions

Cancer

Interventions

blood sampling

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

May 2026

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 7, 2020Actual

Primary Completion Date

Dec 31, 2099Estimated

Completion Date

Dec 31, 2099Estimated

First Submitted Date

Feb 14, 2025

First Submission Date that Met QC Criteria

Feb 24, 2025

First Posted Date

Feb 28, 2025Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 27, 2026

Last Update Posted Date

May 29, 2026Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

40,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
principal		blood sampling	Other: blood sampling

Interventions

Name	Type	Description	Arm Group Labels	Other Names
blood sampling	Other	36ml of blood will be taken during a blood sampling performed in standard practice	principal

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Prediction	The aim of this project is to make a biobank in prevision of MR004 sub-projects which define specific biomarkers studied to identify biomarkers predictive of response.	day 1

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,
Patient who has read the information note and stated that he/she has no objections
Patient who has not objected to the use of this data for medical research purposes
Patient with social security cover.

Exclusion Criteria:

Patient already included in the study
Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Patients with cancer receiving care at Centre Antoine Lacassagne are prospectively recruited for biospecimen collection during routine clinical blood sampling.

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Victoria FERRARI, Dr	Contact	+33 492031311		victoria.ferrari@nice.unicancer.fr

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Centre Antoine Lacassagne	Recruiting	Nice		0600	France

IPD Sharing Statement Module

Plan to Share IPD

Yes

Description

pseudonymised data will only be collected

Types

Study Protocol
Clinical Study Report (CSR)

Time Frame

at the end of study

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D009369	Neoplasms

Ancestor Terms

Not provided

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D001800	Blood Specimen Collection

Ancestor Terms

ID	Term
D013048	Specimen Handling
D019411	Clinical Laboratory Techniques
D019937	Diagnostic Techniques and Procedures
D003933	Diagnosis

Browse Leaves

Not provided

Browse Branches

Not provided